Midazolam medicine and preparation method thereof
The midazolam medicine is prepared from the following components in percentage by weight: the patch is administrated in a transdermal absorption way, the first-pass effect of the liver can be remarkably reduced, the controlled-release and slow-release functions are improved, and the midazolam medicine is stable in property, safe, effective and small in skin irritation and toxicity. The invention also provides a preparation method of the midazolam medicine..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 04. Nov. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ZHU HUAIBAI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-11-04, Last update posted on www.tib.eu: 2024-04-01, Last updated: 2024-04-09 |
|---|
| Patentnummer: |
CN115282153 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002885182 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002885182 | ||
| 003 | DE-627 | ||
| 005 | 20240409142248.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA002885182 | ||
| 035 | |a (EPA)CN115282153 | ||
| 035 | |a (EPA)83818936 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ZHU HUAIBAI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Midazolam medicine and preparation method thereof |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-11-04, Last update posted on www.tib.eu: 2024-04-01, Last updated: 2024-04-09 | ||
| 520 | |a The midazolam medicine is prepared from the following components in percentage by weight: the patch is administrated in a transdermal absorption way, the first-pass effect of the liver can be remarkably reduced, the controlled-release and slow-release functions are improved, and the midazolam medicine is stable in property, safe, effective and small in skin irritation and toxicity. The invention also provides a preparation method of the midazolam medicine. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a HE YAN |e verfasserin |4 aut | |
| 700 | 0 | |a ZHENG YONGGANG |e verfasserin |4 aut | |
| 700 | 0 | |a TAO LIANG |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 04. Nov. |
| 773 | 1 | 8 | |g year:2022 |g day:04 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/83818936/publication/CN115282153A1?q=CN115282153 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 04 |c 11 | ||